147 related articles for article (PubMed ID: 11575855)
1. Immunostaining for ret oncogene proteins in papillary thyroid carcinoma: a correlation of ret immunoreactivity and potential of lymph node metastasis.
Mai KT; Vaccani JP; Thomas J; Odell PF
Thyroid; 2001 Sep; 11(9):859-63. PubMed ID: 11575855
[TBL] [Abstract][Full Text] [Related]
2. Ret oncogene protein expression in papillary thyroid carcinoma and related lesions.
Mai KT; Landry DC; Thomas J; Yazdi HM; Perkins DG; Odell PF
Tumori; 2001; 87(3):166-72. PubMed ID: 11504372
[TBL] [Abstract][Full Text] [Related]
3. Follicular adenoma with papillary architecture: a lesion mimicking papillary thyroid carcinoma.
Mai KT; Landry DC; Thomas J; Burns BF; Commons AS; Yazdi HM; Odell PF
Histopathology; 2001 Jul; 39(1):25-32. PubMed ID: 11454041
[TBL] [Abstract][Full Text] [Related]
4. ret/PTC expression may be associated with local invasion of thyroid papillary carcinoma.
Miki H; Kitaichi M; Masuda E; Komaki K; Yamamoto Y; Monden Y
J Surg Oncol; 1999 Jun; 71(2):76-81; discussion 81-2. PubMed ID: 10389862
[TBL] [Abstract][Full Text] [Related]
5. ret/PTC-1, -2, and -3 oncogene rearrangements in human thyroid carcinomas: implications for metastatic potential?
Sugg SL; Zheng L; Rosen IB; Freeman JL; Ezzat S; Asa SL
J Clin Endocrinol Metab; 1996 Sep; 81(9):3360-5. PubMed ID: 8784097
[TBL] [Abstract][Full Text] [Related]
6. RET/PTC activation in hyalinizing trabecular tumors of the thyroid.
Papotti M; Volante M; Giuliano A; Fassina A; Fusco A; Bussolati G; Santoro M; Chiappetta G
Am J Surg Pathol; 2000 Dec; 24(12):1615-21. PubMed ID: 11117781
[TBL] [Abstract][Full Text] [Related]
7. RET oncogene activation in papillary thyroid carcinoma.
Tallini G; Asa SL
Adv Anat Pathol; 2001 Nov; 8(6):345-54. PubMed ID: 11707626
[TBL] [Abstract][Full Text] [Related]
8. [Expressions of wildtype-RET and RET/PTC rearrangements in sporadic adult papillary thyroid carcinoma and their clinicopathologic correlation].
Zhu XL; Zhou XY; Zhang TM; Zhu XZ
Zhonghua Bing Li Xue Za Zhi; 2006 Feb; 35(2):87-91. PubMed ID: 16630482
[TBL] [Abstract][Full Text] [Related]
9. Hybrid thyroid carcinoma with a coarse chromatin pattern and nuclear features of papillary thyroid carcinoma.
Mai KT; Bokhary R; Yazdi HM; Thomas J
Pathol Res Pract; 2002; 198(4):253-60. PubMed ID: 12049333
[TBL] [Abstract][Full Text] [Related]
10. RET activation and clinicopathologic features in poorly differentiated thyroid tumors.
Santoro M; Papotti M; Chiappetta G; Garcia-Rostan G; Volante M; Johnson C; Camp RL; Pentimalli F; Monaco C; Herrero A; Carcangiu ML; Fusco A; Tallini G
J Clin Endocrinol Metab; 2002 Jan; 87(1):370-9. PubMed ID: 11788678
[TBL] [Abstract][Full Text] [Related]
11. The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids.
Powell DJ; Russell J; Nibu K; Li G; Rhee E; Liao M; Goldstein M; Keane WM; Santoro M; Fusco A; Rothstein JL
Cancer Res; 1998 Dec; 58(23):5523-8. PubMed ID: 9850089
[TBL] [Abstract][Full Text] [Related]
12. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes.
Tallini G; Santoro M; Helie M; Carlomagno F; Salvatore G; Chiappetta G; Carcangiu ML; Fusco A
Clin Cancer Res; 1998 Feb; 4(2):287-94. PubMed ID: 9516913
[TBL] [Abstract][Full Text] [Related]
13. Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer.
Fusco A; Chiappetta G; Hui P; Garcia-Rostan G; Golden L; Kinder BK; Dillon DA; Giuliano A; Cirafici AM; Santoro M; Rosai J; Tallini G
Am J Pathol; 2002 Jun; 160(6):2157-67. PubMed ID: 12057919
[TBL] [Abstract][Full Text] [Related]
14. RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults.
Elisei R; Romei C; Vorontsova T; Cosci B; Veremeychik V; Kuchinskaya E; Basolo F; Demidchik EP; Miccoli P; Pinchera A; Pacini F
J Clin Endocrinol Metab; 2001 Jul; 86(7):3211-6. PubMed ID: 11443191
[TBL] [Abstract][Full Text] [Related]
15. Sporadic ret-rearranged papillary carcinoma of the thyroid: a subset of slow growing, less aggressive thyroid neoplasms?
Soares P; Fonseca E; Wynford-Thomas D; Sobrinho-Simões M
J Pathol; 1998 May; 185(1):71-8. PubMed ID: 9713362
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of RET/PTC expression in papillary thyroid carcinoma and its correlation with prognostic factors in a north Indian population.
Mishra A; Agrawal V; Krishnani N; Mishra SK
J Postgrad Med; 2009; 55(3):171-5. PubMed ID: 19884740
[TBL] [Abstract][Full Text] [Related]
17. Ret oncogene activation in papillary thyroid carcinoma: prevalence and implication on the histological parameters.
Lam AK; Montone KT; Nolan KA; Livolsi VA
Hum Pathol; 1998 Jun; 29(6):565-8. PubMed ID: 9635675
[TBL] [Abstract][Full Text] [Related]
18. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X
Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.
Yu XM; Lo CY; Chan WF; Lam KY; Leung P; Luk JM
Clin Cancer Res; 2005 Nov; 11(22):8063-9. PubMed ID: 16299237
[TBL] [Abstract][Full Text] [Related]
20. Lymphatic endothelial cancerization in papillary thyroid carcinoma: hidden evidence of lymphatic invasion.
Mai KT; Truong LD; Ball CG; Olberg B; Lai CK; Purgina B
Pathol Int; 2015 May; 65(5):220-30. PubMed ID: 25722068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
